“Trade Finance and Reimbursement Agreement (for the primary purpose of supporting the general corporate business of the European subsidiaries of Enron Corp)”
“WHEREAS (A) The Company requires from time to time the issue of letters of credit, bid bonds, performance bonds, guarantees and other instruments, primarily (but not exclusively) in support of the European business and operations of itself and its Subsidiaries and Related Entities including Enron Europe Limited and Enron Metals Limited. (B) The issuing Bank shall issue such letters of credit, bid bonds, performance bonds, guarantees and other instruments on the terms and subject to the conditions set out in this Agreement. ………… “Instrument” means a letter of credit, guarantee indemnity, performance bond or bid bond or such other form of instrument as the Company and issuing Bank may from time to time agree, each such Instrument to be substantially in a form agreed by the Company and the Issuing Bank on or prior to the date of this Agreement or in such other form as the Issuing Bank may from time to time approve, such approval not to be unreasonably withheld or delayed. …………. “Related Entity” means, in relation to the Company, any person in which the Company holds, directly or indirectly, any shares, voting rights or other ownership interests. …………. “Subsidiary” of any Person means any corporation, partnership, joint venture, or other entity of which more than 50% of the outstanding capital stock or other equity interests having ordinary voting power (irrespective of whether or not at the time capital stock or other equity interest of any other class or classes occurrence of any contingency) is at the time owned directly or indirectly by such Person; provided, however, that no such corporation, partnership, joint venture or other entity shall (a) constitute a Subsidiary of the Company, unless such entity of a Consolidated Subsidiary of the Company, or (b) constitute a Subsidiary of any other Person, unless such entity would appear as a consolidated subsidiary of such person on a consolidated balance sheet of such Person prepared in accordance with GAAP. Unless otherwise provided or the context otherwise requires, the term “Subsidiary” when used herein shall refer to a Subsidiary of the Company. ………… 2. INSTRUMENTS 2.1 Instrument Request Subject to the terms and conditions set forth herein, the Company may request (a) the issuance of an Instrument by delivering an “Instrument Issuance Request” substantially in the form attached as Exhibit A-1 properly completed, or (b) the amendment of an outstanding Instrument (including an amendment that extends the term of an Instrument), by delivering an “Instrument Amendment Request” substantially in the form attached as Exhibit A-2 properly completed (each of the Instrument Issuance Request and the Instrument Amendment Request, an “Instrument Request”) to the Issuing Bank at any time and from time to time from the date of this Agreement until the Final Instrument Issuance Date (subject to the provision of Clause 2.2(c) below) by facsimile transmission. Each Instrument Request shall, when issued, be irrevocable. The Issuing Bank shall not be required to issue or amend any Instrument where, if issued or amended, there would be outstanding more than ten (10) Instruments, each with a principal amount of less than$200,000 (or its equivalent). 2.2 Instruments (a) Subject to the terms and conditions set forth herein, and provided that no Default or Event of Default has occurred and is continuing, the Issuing Bank agrees that it will, following its receipt of an Instrument Request prepared in accordance with the terms and conditions of this Agreement, issue one or more Instruments: (i) on the day specified for each issue in any Instrument Request received by the Issuing Bank in accordance with Clause 2.1 not later than 12.00 (noon) (or such later time as the Company and the Issuing Bank m ay agree from time to time) on the date specified in such Instrument Request for the issue of such Instrument; or (ii) on the next following Business Day where such Instrument Request is received by the Issuing Bank after 12.00 (noon) (or such later time as the Company and the Issuing Bank may agree from time to time) on the date specified in such Instrument Request as the date for the issue of such Instrument. (b) Each Instrument will be denominated in Dollars, Sterling, euros or, with the consent of the Banks and the Issuing Bank which shall not be unreasonably withheld or delayed, any other currency which is freely convertible into Dollars, and will be extended for the general corporate purposes of the Company (including such purposes of Enron Europe Limited, Enron Metals Limited and/or any other Related Entity of the Company). Without in any way affecting the obligations of the Company under this Agreement, neither the Issuing Bank nor any Bank shall be obliged to monitor or verify the purpose of any Instrument. (c) The Issuing Bank shall not be required to issue or amend any Instrument under this Agreement where: (i) following the issue of such Instrument, the Total Instrument Disbursement Exposure would exceed the Total Commitments (and upon issuance of amendment of each Instrument, the Company shall be deemed to represent and warrant to that effect. (ii) in the case of an Instrument Amendment Request, the Issuing Bank, acting reasonably and in accordance with good international banking practice, is not reasonably satisfied that such amendment will be acceptable to, or has been accepted by, the beneficiary of the Instrument to which such Instrument Amendment Request relates; or (iii) such Instrument would, if issued in accordance with the Instrument Request, expire at its counters at any time after the close of business on the Final Instrument Expiry Date. The Issuing Bank will notify the Banks promptly following the issuance by the Issuing Bank of an Instrument and may, at its sole discretion, notify the Banks of any material amendment of an Instrument. (d) The Issuing Bank shall not be required to issue any Instrument to the extent that it is aware that the issue of such Instrument would be contrary to any law, regulation, regulatory requirement or directive which is legally binding on or applicable to any Bank in its place of incorporation or in the jurisdiction in which its Funding Office is located at the date of this Agreement or which would be contrary to any official directive, guideline or code of practice, issued by any governmental or regulatory body, applicable to any Bank in any such jurisdiction which, although not having the force of law, is of a type with which institutions of a similar nature to such Bank generally are accustomed to comply, until such Bank is replaced in accordance with Clause 2.14 or until the issue of such Instrument otherwise ceases to be so contrary; provided that the Issuing Bank shall promptly notify the Company of its intention not to issue such Insurance pursuant to this Clause 2.2(d). (e) Subject to Clause 2.2(f), each Instrument will be governed by the laws of England and Wales and, in the case of letters of credit, to the extent not inconsistent with such laws, will incorporate the terms of the UCP 500. ………… 2.6 Fees The Company agrees to pay to the Issuing Bank such fees as are set forth in a separate fee agreement between the Company and the Issuing Bank. In addition, the Company agrees to pay the fees listed in this Clause 2.6 (collectively, “the Fees”). …………….. (a) Commitment Fee. The Company shall pay to the Issuing Bank (for the account of each Bank) a fee in Dollars calculated at the rate of zero decimal four per cent (0.4%) per annum on the undrawn, unutilized and uncancelled amount of such Bank’s Commitment and which shall accrue on a daily basis …………….. (b) Instrument Fees (i) The Company shall pay to the Issuing Bank (for the account of each Bank) a risk weighting fee (the “Instrument Fee”) in respect of each Instrument issued ………. ………….. 3.2 Additional Conditions Precedent to issuance of Each Instrument The obligation of the Issuing Bank to issue or amend any Instrument shall be subject to the additional conditions precedent that on the date of such issuance or amendment, as the case may be, (a) the following statements shall be true (and the giving of the applicable Instrument Request shall constitute a representation and warranty by the Company that on the date of such issuance or amendment, as the case may be such statements are true): (a) The representations and warranties contained in Clause 4.1 of this Agreement are correct on and as if the date of issuance of amendment as the case may be, of such Instrument (other than those set out in Clause 4.1(d) and (e) and other than those representations and warranties that expressly relate solely to a specific earlier date, which shall remain correct as of such earlier date), before and after giving effect to the issuance or amendment as the case may be, of such Instrument and to the application of the proceeds therefrom, as though made on and as of such date, and (b) No event has occurred and is continuing, or would result from such issuance or amendment, as the case may be, of such Instrument which constitutes a Default, an Event of Default or both. ……………. 4. REPRESENTATIONS AND WARRANTIES 4.1 Representations and Warranties of the Company The Company represents and warrants on the date hereof and (other than in relation to those representations and warranties contained in Clause 4.1(d) and (e) on the dates falling at three-monthly intervals thereafter, as follows: …………. (d) The audited consolidated balance sheet of the Company and its Subsidiaries as of December 31, 2000 and the related audited consolidated statements of income, cash flows and changes in stockholders’ equity accounts for the fiscal year then ended and the unaudited consolidated balance sheet of the Company and it Subsidiaries as of March 21, 2001 and the related unaudited consolidated statements of income, cash flows and changes in stockholders’ equity accounts for the three months then ended, certified by the chief financial or accounting officer of the Company, copies of which have been delivered to each of the Banks, fairly present, in conformity with GAAP except as otherwise expressly noted therein, the consolidated financial position of the Company and its Subsidiaries as of such dates and their consolidated results of operations and changes in financial position for such fiscal periods, subject (in the case of the unaudited balance sheet and statements) to changes resulting from audit and normal year end adjustments. (e) Since December 31, 2000 through the date hereof, there has been no material adverse change in the business, consolidated financial position or consolidated results of operations of the company and its Subsidiaries considered as a whole. ………… 5.1 Affirmative Covenants The Company covenants agree that so long as any Instrument shall remain outstanding, any Instrument Obligation shall remain unpaid or any Bank shall have any Commitment hereunder, the Company will, unless the Majority Banks shall otherwise consent in writing: …………. (b) Compliance with Laws, Etc Comply, and cause each of its Subsidiaries to comply with all applicable laws, rules, regulations and orders to the extent non-compliance therewith would have a material adverse effect on the Company and its Subsidiaries taken as a whole, such compliance to include, without limitation, compliance with environmental laws and the paying before the same become delinquent of all taxes, assessments and governmental charges imposed upon it or upon its property except to the extent contests in good faith. (c) Use of proceeds: Request the issuance of an instrument only of general corporate purposes of the company (including such purposes of any Related Entity of the Company) not in violation of Clause 5.2 (f). ………….. 5.2 Negative Covenants So long as any Instrument shall remain outstanding, any Instrument Obligation shall remain unpaid or any Bank shall have any Commitment hereunder, the Company will not at any time, without the written consent of the Majority Banks: ………….. (f) Use of Proceeds Use any Instrument or the proceeds of any Instrument for any purpose other than for general corporate purposes of the Company (including such payment of any Related Entity of the Company), or use any Instrument or such proceed (i) in a manner which violates or results in a violation of any law or regulation, (ii) to purchase or carry any margin stock (as defined in Regulation 11 issued by the Federal Reserve Board) or to extend credit to others for that purpose or (iii) to make nay investment in any person if such investment is opposed by the board of directors, general partner or other governing body of such Person. 6. EVENTS OF DEFAULT 6.1 Events of Default If any of the following events (“Events of Default”) shall occur and be continuing: ……………… (b) Any representation or warranty made by the Company (or any of its officers) (including representations and warranties deemed made pursuant to Clause 3.2), under or in connection with any Facility Document shall prove to have been incorrect in any material respect when made or deemed made and such materiality is continuing; or (c) The Company shall fail to perform or observe any terms, covenant or agreement contained in Clause 5.2 or shall fail to perform or observe any other term, covenant or agreement contained in any Facility Document on its part to be performed or observed if, in the case of such other term, covenant or agreement, such failure shall remain unremedied for 30 days after written notice thereof shall have been given to the Company by the Issuing Bank at the request of any Bank; or …………….. then, and in any event, the Issuing Bank (i) shall at the request, or may with the consent, of the Majority Bank, by notice to the Company declare the obligation of the Issuing Bank to issue further Instruments, or amend Instruments already issued to be terminated, whereupon such obligation and all of the Commitments shall forthwith terminate, except for obligations to the Issuing Bank in respect of then outstanding Instrument and Instrument Obligations, ………….. 8.7 Governing Law: Service: Entire Agreement (a) This Agreement shall be governed by, and construed in accordance with, the laws of England and Wales. (b) Each of the Company, the Issuing Bank and the Banks irrevocable submits to the non-exclusive jurisdiction of the courts of England in respect of any claim or matter arising out of or in connection with this Agreement. ……….. (d) This Agreement and the other Facility Documents accepted by the Company constitute the entire understanding among the parties hereto with respect to the subject matter hereof and supersede any prior agreements, written or oral, with respect thereto.”
“NICOLA KERR: Yes, I understood that it would be different types of indemnities (inaudible) bonds, bid bonds, guarantees, standby LCs or – JERRY EDEY: The instruments are alright, the instruments are fine. RICHARD SAINT: It’s purely that it’s not collateralising other bilateral facilities. JERRY EDEY: Bank Loans – TIM SAI LOUIE: Correct ROBERT BOURKE: Or something like that SOPHIE MARTIN: Oh, right, Okay, yeah, well it’s not the intention SIMON CROWE: That’s not the intention RICHARD SAINT: That was all our point (overspeaking) SOPHIE MARTIN: Well, we – hey, that’s a good idea though! Overspeaking ROBERT BOURKE: (overspeaking) margin (ovespeaking) 50 basis points on WestLB risk. Okay, Tim will draft up (inaudible) tighten that clause. TIM SAI LOUIE: So, basically we’re agreed commercially that it’s basically trade related and inter-company and other things are excluded? SIMON CROWE: Trade related in the page 1 is going.”
“FASB Concepts Statement No.1, Objectives of Financial Reporting by Business Enterprises, paragraph 37, states that “…financial reporting should provide information to help investors, creditors, and others assess the amounts, timing, and uncertainty of prospective net cash inflows to the related enterprise”
“Enron loves these deals as they are able to hide funded debt from their equity analysts because they (at the very least) book it as deferred rev or (better yet) bury it in their trading liabilities. There are however tax attributes to the structure that can ‘freshen’ NOL’s. (Net operating losses) …sale can accelerate gains to the year in which the prepay is consummated which gains can be offset by expiring NOLs.”
“So they could go to them direct. I wouldn’t be surprised if they did. Literally, they do like an ISDA Swap and just prepay it. ”
“We just don’t think it’s conceivable, Joe, that even if we do a deal by month end, given the experience we’ve had and given the way that lawyers will look in these documents to try to find ways that their banks are being screwed or potentially going to have to suffer in a meltdown, we have to give them something simple to evaluate”